相似文献
1
Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology.
Thorax. 2004 Jun;59(6):529-35. doi: 10.1136/thx.2003.006528.
2
Molecular basis of α1-antitrypsin deficiency revealed by the structure of a domain-swapped trimer.
EMBO Rep. 2011 Sep 30;12(10):1011-7. doi: 10.1038/embor.2011.171.
3
Alpha1-antitrypsin deficiency: liver disease associated with retention of a mutant secretory glycoprotein in the endoplasmic reticulum.
Methods Mol Biol. 2003;232:39-56. doi: 10.1385/1-59259-394-1:39.
4
Molecular pathogenesis of alpha-1-antitrypsin deficiency.
Rev Mal Respir. 2014 Dec;31(10):992-1002. doi: 10.1016/j.rmr.2014.03.015. Epub 2014 Nov 20.
5
A transgenic zebrafish model of hepatocyte function in human Z α1-antitrypsin deficiency.
Biol Chem. 2019 Nov 26;400(12):1603-1616. doi: 10.1515/hsz-2018-0391.
6
A novel monoclonal antibody to characterize pathogenic polymers in liver disease associated with alpha1-antitrypsin deficiency.
Hepatology. 2010 Sep;52(3):1078-88. doi: 10.1002/hep.23760.
7
The molecular species responsible for α -antitrypsin deficiency are suppressed by a small molecule chaperone.
FEBS J. 2021 Apr;288(7):2222-2237. doi: 10.1111/febs.15597. Epub 2020 Nov 11.
8
Polymerisation underlies alpha1-antitrypsin deficiency, dementia and other serpinopathies.
Front Biosci. 2004 Sep 1;9:2873-91. doi: 10.2741/1444.
9
Twenty years of polymers: a personal perspective on alpha-1 antitrypsin deficiency.
COPD. 2013 Mar;10 Suppl 1:17-25. doi: 10.3109/15412555.2013.764401.
10
Lung polymers in Z alpha1-antitrypsin deficiency-related emphysema.
Am J Respir Cell Mol Biol. 1998 May;18(5):670-4. doi: 10.1165/ajrcmb.18.5.3065.
引用本文的文献
1
Heterozygous Defects and Their Impact on Clinical Manifestations of Patients with Predominantly Antibody Deficiencies.
Int J Mol Sci. 2024 May 15;25(10):5382. doi: 10.3390/ijms25105382.
2
Computational Tools to Assist in Analyzing Effects of the Gene Variation on Alpha-1 Antitrypsin (AAT).
Genes (Basel). 2024 Mar 6;15(3):340. doi: 10.3390/genes15030340.
3
Prevalence of Cardiovascular Disease and Rate of Major Adverse Cardiovascular Events in Severe Alpha-1 Antitrypsin Deficiency COPD.
Int J Chron Obstruct Pulmon Dis. 2024 Jan 17;19:149-159. doi: 10.2147/COPD.S419846. eCollection 2024.
4
Utility of the Serum Protein Electrophoresis in the Opportunistic Screening for the Deficiency of Alpha-1 Antitrypsin.
Diagnostics (Basel). 2023 Aug 28;13(17):2778. doi: 10.3390/diagnostics13172778.
5
Safety of Intravenous Administration of an AAV8 Vector Coding for an Oxidation-Resistant Human α1-Antitrypsin for the Treatment of α1-Antitrypsin Deficiency.
Hum Gene Ther. 2023 Feb;34(3-4):139-149. doi: 10.1089/hum.2022.192.
6
Recombinant Alpha-1 Antitrypsin as Dry Powder for Pulmonary Administration: A Formulative Proof of Concept.
Pharmaceutics. 2022 Dec 8;14(12):2754. doi: 10.3390/pharmaceutics14122754.
7
A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application.
Int J Mol Sci. 2022 Feb 23;23(5):2441. doi: 10.3390/ijms23052441.
8
In Vivo Electroporation-Mediated, Intrahepatic Alpha1 Antitrypsin Gene Transfer Reduces Pulmonary Emphysema in Pallid Mice.
Pharmaceutics. 2020 Aug 21;12(9):793. doi: 10.3390/pharmaceutics12090793.
9
Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin.
JCI Insight. 2020 Aug 6;5(15):135951. doi: 10.1172/jci.insight.135951.
10
Molecular diagnosis of alpha1-antitrypsin deficiency: A new method based on Luminex technology.
J Clin Lab Anal. 2020 Jul;34(7):e23279. doi: 10.1002/jcla.23279. Epub 2020 Mar 17.
本文引用的文献
1
EXPERIMENTAL EMPHYSEMA: ITS PRODUCTION WITH PAPAIN IN NORMAL AND SILICOTIC RATS.
Arch Environ Health. 1965 Jul;11:50-8. doi: 10.1080/00039896.1965.10664169.
2
[alpha1-Antitrypsin from human serum].
Klin Wochenschr. 1962 Apr 15;40:427-9. doi: 10.1007/BF01732842.
3
Targeting a surface cavity of alpha 1-antitrypsin to prevent conformational disease.
J Biol Chem. 2003 Aug 29;278(35):33060-6. doi: 10.1074/jbc.M302646200. Epub 2003 Jun 13.
4
Nucleation of alpha 1-antichymotrypsin polymerization.
Biochemistry. 2003 Mar 4;42(8):2355-63. doi: 10.1021/bi0259305.
5
Drosophila necrotic mutations mirror disease-associated variants of human serpins.
Development. 2003 Apr;130(7):1473-8. doi: 10.1242/dev.00350.
6
Serpin polymerization is prevented by a hydrogen bond network that is centered on his-334 and stabilized by glycerol.
J Biol Chem. 2003 Apr 25;278(17):15116-22. doi: 10.1074/jbc.M211663200. Epub 2003 Feb 10.
7
Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy.
J Clin Invest. 2002 Dec;110(11):1585-90. doi: 10.1172/JCI16782.
8
Liver injury in alpha1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury.
J Clin Invest. 2002 Dec;110(11):1579-83. doi: 10.1172/JCI16787.
9
Serpinopathies and the conformational dementias.
Nat Rev Genet. 2002 Oct;3(10):759-68. doi: 10.1038/nrg907.
10
Interactions causing the kinetic trap in serpin protein folding.
J Biol Chem. 2002 Nov 29;277(48):46347-54. doi: 10.1074/jbc.M207682200. Epub 2002 Sep 18.
Zotero 插件